Literature DB >> 10589550

Amyloid beta protein species in cerebrospinal fluid and in brain from patients with Down's syndrome.

A Tamaoka, Y Sekijima, S Matsuno, T Tokuda, S Shoji, S I Ikeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10589550     DOI： 10.1002/1531-8249(199912)46:6<933::aid-ana20>3.0.co;2-4

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  10 in total

1.  The AT(N) framework for Alzheimer's disease in adults with Down syndrome.

Authors:  Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-27

Review 2.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome.

Authors:  Erik Portelius; Mikko Hölttä; Hilkka Soininen; Maria Bjerke; Henrik Zetterberg; Anni Westerlund; Sanna-Kaisa Herukka; Kaj Blennow; Niklas Mattsson
Journal:  Neuromolecular Med       Date:  2014-04-18       Impact factor: 3.843

4.  Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review.

Authors:  Melissa E Petersen; Sid E O'Bryant
Journal:  Dev Neurobiol       Date:  2019-09-03       Impact factor: 3.964

Review 5.  A Review of Biomarkers for Alzheimer's Disease in Down Syndrome.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Neurol Ther       Date:  2017-07-21

6.  Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome.

Authors:  Alain D Dekker; Juan Fortea; Rafael Blesa; Peter P De Deyn
Journal:  Alzheimers Dement (Amst)       Date:  2017-03-20

7.  Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome.

Authors:  Melissa Petersen; Fan Zhang; Sharon J Krinsky-McHale; Wayne Silverman; Joseph H Lee; Deborah Pang; James Hall; Nicole Schupf; Sid E O'Bryant
Journal:  Alzheimers Dement (Amst)       Date:  2020-04-17

Review 8.  Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease.

Authors:  Hem Prakash Karki; Yeongseok Jang; Jinmu Jung; Jonghyun Oh
Journal:  J Nanobiotechnology       Date:  2021-03-09       Impact factor: 10.435

9.  Acute Regression in Down Syndrome.

Authors:  Benjamin Handen; Isabel Clare; Charles Laymon; Melissa Petersen; Shahid Zaman; Sid O'Bryant; Davneet Minhas; Dana Tudorascu; Stephanie Brown; Bradley Christian
Journal:  Brain Sci       Date:  2021-08-23

10.  Cerebrospinal fluid and blood Aβ levels in Down syndrome patients with and without dementia: a meta-analysis study.

Authors:  Yang Du; Lei Chen; Yuguo Jiao; Yong Cheng
Journal:  Aging (Albany NY)       Date:  2019-12-20       Impact factor: 5.682
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.